Elaboración de un plan de seguridad en una unidad de gestión clínica del medicamento

Gómez, Ernesto Sánchez; Rivas, L. González; Moral, Raquel Sánchez del

doi:10.1016/j.cali.2010.01.006

Cited by 4 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the patient safety plan designed by the pharmacy unit of Juan Ramón Jiménez Hospital, Huelva, Spain, 55 specific risks distributed across eight areas of pharmaceutical care were identified 29. The results obtained were consistent with those of our study, where 42 risks distributed across 8 pharmacy areas were identified.…”

Section: Discussionsupporting

confidence: 86%

Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysis

et al. 2017

View full text Add to dashboard Cite

ObjectivesThe goals of this project included identifying the processes and subprocesses performed in hospital pharmacies, identifying potential adverse events, detecting failure modes and the causes of errors, prioritising the risks identified and designing a map of risks for hospital pharmacies.MethodsA task force composed of hospital pharmacy staff was committed to update the diagram of processes and design a map of processes performed in hospital pharmacies. Risks were identified by failure mode and effect analysis annd prioritised according to their risk priority index (RPI) and criticality. A risk map of adverse events was designed based on the diagram of processes and/or primary activities where the prioritised failure modes were most frequent.ResultsIn total, 99 failure modes associated with 80 adverse events and 129 causes were identified in eight hospital pharmacy areas/subprocesses. The three areas with the highest percentages of failure modes were inpatient pharmaceutical care, pharmacy laboratory and pharmaceutical technology, and medication management. The 25 failure modes (first quartile) with the highest RPI scores (RPI≥20) and the 25 failure modes with the highest frequency and criticality scores were classified as priority.ConclusionsAccording to their RPI, priority failure modes mostly occurred in the area of inpatient pharmaceutical care (92%). However, according to their criticality, priority failure modes were found to homogeneously occur across all pharmaceutical care areas. As general recommendations pharmacists should assume responsibility and leadership in the implementation of safe medication use practices in healthcare centres.

show abstract

Section: Discussionsupporting

confidence: 86%

Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysis

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Since then, the number of publications has not followed a linear pattern over the years (Figure 2). In 2010 and 2012, the area reached the maximum number of papers on the theme published in one year (seven), of which six were articles [21][22][23][24][25]49 and one, a doctoral dissertation, 53 in 2010, and six articles [17][18][19]46,48,52 and a master dissertation, 47 in 2012. In 2008 there was no publication on the subject of this study.…”

Section: /18mentioning

confidence: 99%

“…The other studies were published in different health journals. 3,[13][14][15][16]19,21,[24][25]31,33,43,[36][37]39,42,47,[49][50] The safety of cancer drug administration in adults, children and young people in hospitals, [3][4][6][7][13][14][15][16][17][18][19][20][21][22]27,33,[35][36][40][41]44,[47][48][49][50]52 outpatient clinics, [3][4][5][16][17][18][19...…”

Section: /18mentioning

confidence: 99%

“…The recommendations found in the studies to avoid them were the following: implement processes to verify CTX regimen prescriptions prior to administration; implement the double-check process, careful and standardized; promote training and continuing education of nurses working in oncology; provide guidelines for patients and families (educational materials appropriate to their level of literacy and understanding, validated by health professionals and target audience); encourage patients to question their treatment and empower them to be able to actively participate in their own care; standardize CTX and immunotherapy administration procedures; perform computerized prescription. [4][5][6][7]13,[19][20]22,[24][25][27][28][29][30][33][34]36,44,47,[49][50][51][52][53] Diverse studies stood out that signaled as essential the use of tools for managing risks related to drugs, such as the HFMEA (Healthcare Failure Mode and Effect Analysis) and Lean Sigma, methodologies used to map, evaluate and propose the control of incidents before they occur and to detect hidden incidents in the system, error reporting and surveillance systems; a checklist of items for safe administration of antineoplastic drugs. 22,25,28,30,37,42,44…”

Section: Prevention and Management Of Errors Related To The Administrmentioning

confidence: 99%

See 1 more Smart Citation

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

Oliveira

Santos

Bezerril

et al. 2019

Texto contexto - enferm.

View full text Add to dashboard Cite

Objective: to identify and synthesize the scientific evidence on cancer patient safety in the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Method: a scoping review, according to the Joanna Briggs Institute and to the recommendations of the PRISMA-ScR international guide. The research was conducted in five electronic databases, the Cochrane Library and eight catalogs of theses and dissertations. The inclusion criteria were the following: studies related to patient safety in the administration of antineoplastic and immunotherapeutic chemotherapy by nurses in places where cancer care occurs, published entirely in Portuguese, Spanish and/or English, with no time limit. The extracted data were analyzed and synthesized in narrative form. Results: a total of 14,444 records were retrieved and 47 studies were kept for review. Most publications (44.7%) had a qualitative approach, while 40.4% were quantitative and 14.9%, mixed. When summarizing the findings, the following themes emerged: Safety standards in parenteral administration of antineoplastic chemotherapy; Good practices for patient safety using oral antineoplastic therapy; Administration and safe handling of immunotherapies; Prevention and management of errors related to the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Conclusion: patients safety with cancer in the administration of antineoplastic therapy occurs when there is implementation of evidence-based protocols, continuing education of nurses and implementation of safety standards and processes, as a strategy to prevent errors in drug administration.

show abstract

Soluciones aportadas por Atención Primaria para abordar los riesgos relacionados con la seguridad del paciente

Castellano-Zurera

Núñez-García

Carrasco-Peralta

et al. 2012

Revista de Calidad Asistencial

View full text Add to dashboard Cite

Elaboración de un plan de seguridad en una unidad de gestión clínica del medicamento

Cited by 4 publications

References 4 publications

Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysis

Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysis

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

Soluciones aportadas por Atención Primaria para abordar los riesgos relacionados con la seguridad del paciente

Contact Info

Product

Resources

About